Fda guidance industry acne medication
Guidance for Industry Acne Vulgaris Developing Drugs for Treatment (PDF 17P) Ratings. This document is intended to provide guidance to the pharmaceutical industry on the development of drug products for the treatment of acne vulgaris other than nodulocysticacne. Apr 01, · (ii) The labeling states "When using this product [bullet] skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time." (2) For products containing sulfur identified in (e) and (f). Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment. Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) May Clinical/Medical. Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment.